These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 15111771)

  • 1. Hormonal factors and breast tumor proliferation: do factors that affect cancer risk also affect tumor growth?
    Oestreicher N; White E; Malone KE; Porter PL
    Breast Cancer Res Treat; 2004 May; 85(2):133-42. PubMed ID: 15111771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of regimens of hormone replacement therapy to prognostic factors among women diagnosed with breast cancer aged 50-64 years.
    Daling JR; Malone KE; Doody DR; Voigt LF; Bernstein L; Marchbanks PA; Coates RJ; Norman SA; Weiss LK; Ursin G; Burkman RT; Deapen D; Folger SG; McDonald JA; Simon MS; Strom BL; Spirtas R
    Cancer Epidemiol Biomarkers Prev; 2003 Nov; 12(11 Pt 1):1175-81. PubMed ID: 14652277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Female sex hormones increase the risk of breast cancer].
    Vatten L
    Tidsskr Nor Laegeforen; 1998 Aug; 118(19):2969-74. PubMed ID: 9748837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormone replacement therapy and cancer.
    Gynecol Endocrinol; 2001 Dec; 15(6):453-65. PubMed ID: 11826770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Puberty and genetic susceptibility to breast cancer in a case-control study in twins.
    Hamilton AS; Mack TM
    N Engl J Med; 2003 Jun; 348(23):2313-22. PubMed ID: 12788995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of breast cancer in post-menopausal women using hormone replacement therapy.
    Ratanawichitrasin A; Reansuwan W; Ratanawichitrasin S; Bhodhisuwan K; Kongpatanakul S
    J Med Assoc Thai; 2002 May; 85(5):583-9. PubMed ID: 12188389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age and menopausal effects of hormonal birth control and hormone replacement therapy in relation to breast cancer risk.
    Shantakumar S; Terry MB; Paykin A; Teitelbaum SL; Britton JA; Moorman PG; Kritchevsky SB; Neugut AI; Gammon MD
    Am J Epidemiol; 2007 May; 165(10):1187-98. PubMed ID: 17337757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.
    Genazzani AR; Gadducci A; Gambacciani M
    Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variability of breast cancer risk in observational studies of hormone replacement therapy: a meta-regression analysis.
    Garbe E; Levesque L; Suissa S
    Maturitas; 2004 Mar; 47(3):175-83. PubMed ID: 15036487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogens reduce and withdrawal of estrogens increase risk of microsatellite instability-positive colon cancer.
    Slattery ML; Potter JD; Curtin K; Edwards S; Ma KN; Anderson K; Schaffer D; Samowitz WS
    Cancer Res; 2001 Jan; 61(1):126-30. PubMed ID: 11196149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast cancer risk factors and second primary malignancies among women with breast cancer.
    Trentham-Dietz A; Newcomb PA; Nichols HB; Hampton JM
    Breast Cancer Res Treat; 2007 Oct; 105(2):195-207. PubMed ID: 17186360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of hormone replacement therapy to estrogen and progesterone receptor status in invasive breast carcinoma.
    Chen WY; Hankinson SE; Schnitt SJ; Rosner BA; Holmes MD; Colditz GA
    Cancer; 2004 Oct; 101(7):1490-500. PubMed ID: 15378477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relation of reproductive factors to mortality from breast cancer.
    Daling JR; Malone KE; Doody DR; Anderson BO; Porter PL
    Cancer Epidemiol Biomarkers Prev; 2002 Mar; 11(3):235-41. PubMed ID: 11895871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma sex hormone concentrations and subsequent risk of breast cancer among women using postmenopausal hormones.
    Tworoger SS; Missmer SA; Barbieri RL; Willett WC; Colditz GA; Hankinson SE
    J Natl Cancer Inst; 2005 Apr; 97(8):595-602. PubMed ID: 15840882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prenatal and perinatal correlates of adult mammographic breast density.
    Cerhan JR; Sellers TA; Janney CA; Pankratz VS; Brandt KR; Vachon CM
    Cancer Epidemiol Biomarkers Prev; 2005 Jun; 14(6):1502-8. PubMed ID: 15941963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Duration of hormone replacement therapy, breast tumour size and grade in a screening programme.
    Gertig DM; Erbas B; Fletcher A; Amos A; Kavanagh AM
    Breast Cancer Res Treat; 2003 Aug; 80(3):267-73. PubMed ID: 14503799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of paternal age at birth and the risk of breast cancer in offspring: a case control study.
    Choi JY; Lee KM; Park SK; Noh DY; Ahn SH; Yoo KY; Kang D
    BMC Cancer; 2005 Oct; 5():143. PubMed ID: 16259637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormone replacement therapy containing progestins and given continuously increases breast carcinoma risk in Sweden.
    Olsson HL; Ingvar C; Bladström A
    Cancer; 2003 Mar; 97(6):1387-92. PubMed ID: 12627501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex steroid hormones and breast cancer: is there a link with oral contraceptives and hormone replacement therapy?
    Khoo SK; Chick P
    Med J Aust; 1992 Jan; 156(2):124-32. PubMed ID: 1736053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association of reproductive factors and breastfeeding with long term survival from breast cancer.
    Alsaker MD; Opdahl S; Asvold BO; Romundstad PR; Vatten LJ
    Breast Cancer Res Treat; 2011 Nov; 130(1):175-82. PubMed ID: 21553291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.